DSGN

Design Therapeutics Inc (DSGN)

US
$ 4.105-9.18%

Price Chart

Key Statistics

Market Cap
$ 221.4M
P/E Ratio
0.00
Revenue (TTM)
$ 33K
Volume
395.35K
52W High
$ 7.77
52W Low
$ 2.60
Dividend Yield
0.00%
Beta
1.62

Technicals

50-Day MA
3.7317
200-Day MA
4.8983
52 Week High
7.77
52 Week Low
2.6

About DSGN

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the Unit.

Employees
56
Headquarters
Carlsbad, CA
CEO
Mr. Pratik Shah Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg